Baker Brothers Life Sciences LP
Director; Director, 10% Owner · 22 filings · Latest: Sep 30, 2026
ACADIA PHARMACEUTICALS INC
BeOne Medicines Ltd.
Denali Therapeutics Inc.
INCYTE CORP
Kiniksa Pharmaceuticals International, plc
Kodiak Sciences Inc.
Kymera Therapeutics, Inc.
MADRIGAL PHARMACEUTICALS, INC.
Prelude Therapeutics Inc
Replimune Group, Inc.
TScan Therapeutics, Inc.
vTv Therapeutics Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
KOD | Baker Brothers Life Sciences LP | Director, 10% Owner | Sep 29, 2026 | Purchase | $85.05 | 33,726 | $2.9M | 20,191,214 | |
KOD | Baker Brothers Life Sciences LP | Director, 10% Owner | Sep 28, 2026 | Purchase | $88.77 | 681,866 | $60.5M | 20,159,386 | |
KOD | Baker Brothers Life Sciences LP | Director, 10% Owner | Sep 28, 2026 | Purchase | $83.58 | 418,323 | $35.0M | 19,515,907 | |
KOD | Baker Brothers Life Sciences LP | Director, 10% Owner | Sep 28, 2026 | Purchase | $72.57 | 807,840 | $58.6M | 19,121,134 | |
CELC | Baker Brothers Life Sciences, L.P. | — | Jul 14, 2026 | Proposed Sale | $102.50 | 2,838,632 | $291.0M | — | |
ONC | Baker Brothers Life Sciences LP | Director | May 22, 2026 | Sale | $23.82 | 10,998 | $262.0K | 142,570 | |
INCY | Baker Brothers Life Sciences LP | Director, 10% Owner | May 8, 2026 | Option Exercise | $84.53 | 30,000 | $2.5M | 28,203,718 | |
TARA | Baker Brothers Life Sciences, L.P. | — | Apr 23, 2026 | Proposed Sale | $5.35 | 300,176 | $1.6M | — | |
TARA | Baker Brothers Life Sciences, L.P. | — | Mar 6, 2026 | Proposed Sale | $5.85 | 461,723 | $2.7M | — | |
TARA | Baker Brothers Life Sciences, L.P. | — | Mar 4, 2026 | Proposed Sale | $6.26 | 424,125 | $2.7M | — | |
TARA | Baker Brothers Life Sciences, L.P. | — | Feb 25, 2026 | Proposed Sale | $5.81 | 947,479 | $5.5M | — | |
TARA | Baker Brothers Life Sciences, L.P. | — | Feb 24, 2026 | Proposed Sale | $6.04 | 322,039 | $1.9M | — | |
ONC | Baker Brothers Life Sciences, L.P. | — | Feb 28, 2025 | Proposed Sale | $260.00 | 671,976 | $174.7M | — | |
ONC | Baker Brothers Life Sciences, L.P. | — | Dec 9, 2024 | Proposed Sale | $187.27 | 950,907 | $178.1M | — |